ArticleHospital pharmacy2022
Carvedilol-Induced Thrombocytopenia: A Case Report.
Article in Hospital pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 3 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thrombocytopenia is a commonly encountered complication of hospitalized patients, and can be caused by many factors including infections, surgery, and medications. Drug-induced thrombocytopenia (DITP) should be considered when a patient presents with an unexpected occurrence of thrombocytopenia. Many drugs can induce thrombocytopenia either as a direct effect on thrombopoiesis within the bone marrow or by drug-dependent antibody-mediated destruction of platelets within the circulation. We present the case of a 44-year-old female who presented with 2 weeks of nausea, vomiting, and headaches occurring with her hemodialysis sessions. On admission she was found to be thrombocytopenic with a platelet count of 35 K/µL. Her last known normal platelet count was 299 K/µL from 2 months prior. A thorough work up of her thrombocytopenia was found to be unremarkable. Her newly started carvedilol was thought to be the most likely cause based on the rapid platelet recovery upon drug discontinuation and negative workup of other potential causes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.